ACM Research (ACMR) Valuation After Q1 2026 Earnings Beat And Reaffirmed Guidance
ACM Research, Inc. Class A ACMR | 0.00 |
ACM Research (ACMR) is back in focus after releasing Q1 2026 results that topped analyst revenue and earnings estimates and reaffirmed full year guidance, supported by strength in electrochemical plating and advanced packaging.
The Q1 2026 beat and reaffirmed guidance come after a sharp share price run, with a 7 day share price return of 19.3% and a 30 day gain of 31.04%, although the stock is still down 10.88% over 90 days. At the current US$62.99 share price, the 1 year total shareholder return of 150.56% and a very large 3 year total shareholder return suggest momentum has been strong over time, even if recent equity issuance and margin pressure have reminded investors that risks are still in play.
If ACM Research’s move has you thinking about other chip related opportunities, this is a good moment to scan the market via our list of 39 AI infrastructure stocks.
With the stock up sharply over the past year, trading at a discount to the average analyst price target but showing margin pressure and fresh equity issuance, you have to ask: is there still a buying opportunity here, or is the market already pricing in future growth?
Most Popular Narrative: 10.7% Undervalued
With ACM Research closing at $62.99 against a narrative fair value of $70.50, the most followed storyline frames the stock as modestly undervalued while still accounting for specific growth and risk assumptions.
Advanced digitalization and AI adoption are driving a surge in demand for next-generation semiconductor manufacturing, with ACM's differentiated cleaning and plating solutions (such as its proprietary N2 bubbling and SPM tools) positioned to capture increased orders as foundries invest in more complex 3D NAND, DRAM, and logic nodes, supporting long-term revenue growth.
Want to see how that growth story is turned into a $70.50 fair value? The narrative leans on rapid earnings compounding, richer margins and a future valuation multiple that still sits below a key industry benchmark.
Result: Fair Value of $70.50 (UNDERVALUED)
However, this story can unravel quickly if China demand softens or export controls tighten, especially with high R&D spend already pressuring profitability and cash flow.
Another Angle: DCF Points to Less Upside
While the popular narrative fair value sits at $70.50, Simply Wall St’s DCF model suggests a value of $50.64. With the current $62.99 price sitting above that estimate and implying the stock could be overvalued on this cash flow view, which story do you find more compelling?
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out ACM Research for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 44 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
With sentiment split between upside potential and valuation risk, this is a moment to move quickly, review the underlying drivers yourself, and weigh the 3 key rewards.
Looking for more investment ideas?
ACM Research might be front of mind today, but the market is full of other stocks that could fit your goals if you know where to look.
- Pinpoint value by scanning companies that screen as 44 high quality undervalued stocks, so you do not miss stocks that trade below their fundamentals.
- Strengthen your core holdings by checking out the solid balance sheet and fundamentals stocks screener (46 results), focusing on businesses with financial structures that may handle tougher conditions.
- Stay ahead of the crowd with a screener containing 22 high quality undiscovered gems, highlighting stocks that have quality metrics yet remain off most investors’ radar.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
